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A B S T R A C T
Purpose: The knowledge about possible relationships between ADHD and epilepsy is largely based on
small samples of ADHD patients and on cohorts with epilepsy. There is insufﬁcient information about the
clinical characteristics of epilepsy among children diagnosed with ADHD. The aim of this study was to
investigate the prevalence and characteristics of epilepsy in a large, unselected cohort of children with
ADHD.
Methods: We conducted a retrospective chart-review of children with ADHD who were evaluated in our
clinic between the years 2000 and 2005. We compared age, sex, disorders of psychological development,
cognitive level, pharmacological treatment for ADHD, initial response to treatment and ADHD subtype
with and without epilepsy. In addition, we compared our data with data from a Norwegian study in a
large general pediatric population.
Results: Of 607 children with ADHD (age 6–14 years; 82.4% males); 14 (2.3%) had a history of epilepsy,
and 13 of these had active epilepsy. This is a higher occurrence than expected in the general pediatric
population (0.5%). The majority of our patients had mild (an easily treated) epilepsy and they were more
likely to be seizure free (79%) compared to the patients with epilepsy in general pediatric population. The
ADHD patients with and without epilepsy did not differ regarding age, gender, disorders of psychological
development, IQ level < 85 or ADHD subtype. The patients had been diagnosed with epilepsy on average
1.8 years before the ADHD assessment. All patients with epilepsy were treated with methylphenidate
(MPH), and initial response to MPH was achieved in 85.7%.
Conclusion: The epilepsy diagnosis preceded the ADHD diagnosis, and was found in a signiﬁcantly higher
rate than would be expected in the general pediatric population. The majority of patients had mild
epilepsy and ADHD-Combined Inattentive/Hyperactive-Impulsive Subtype. All cases with epilepsy and
ADHD were treated with MPH, with initial response achieved in 86%.
 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Attention deﬁcit/hyperactivity disorder (ADHD) occurs in 3–7%
of all children1 whereas the prevalence of epilepsy in the general
population is between 0.4 and 1%.2 ADHD and epilepsy may occur
as comorbid conditions, and a number of studies in different
populations have indicated a reciprocal relationship between
epilepsy and ADHD/ADHD symptoms.3–15 A recent study reported
that epilepsy in children with ADHD appeared to be more severe* Corresponding author at: Stavanger University Hospital, Division of Psychiatry,
PB 8100, 4068 Stavanger, Norway. Tel.: +47 51515937; fax: +47 51518000.
E-mail addresses: dobrinko.socanski@sus.no, socanski@hotmail.com
(D. Socanski).
1059-1311/$ – see front matter  2013 British Epilepsy Association. Published by Else
http://dx.doi.org/10.1016/j.seizure.2013.04.021than in those without, and that clinicians appeared to be reluctant
to diagnose and treat ADHD in children with epilepsy.16 It might be
difﬁcult to differentiate the symptoms of ADHD from those caused
by the seizure disorder itself. The majority of studies investigating
this ﬁeld have considered ADHD in patients who have been
diagnosed with epilepsy,4,6–8,10,17–20 rather than the other way
around. Clinical studies have suggested that the prevalence of
ADHD in epilepsy patients may be as high as 30–40%, with
predominantly inattentive subtype of ADHD (ADHD-I) more
common than ADHD Combined Inattentive/Hyperactive-Impul-
sive subtype (ADHD-C).8 However, one study claimed that
attention difﬁculties are not characteristic of schoolchildren with
newly diagnosed idiopathic or cryptogenic epilepsy,13 and
similarly, one study reported that behavioral problems are not
persistent in the majority of these children,14 and in another studyvier Ltd. All rights reserved.
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in the same-age general population was documented.15
Methods and diagnostic criteria vary widely in studies
investigating associations between epilepsy and ADHD, and
considerable gaps remain in our knowledge regarding the extent
of epileptic seizures (ESz) and epileptic syndromes in children with
ADHD. Although ADHD is a common neuropsychiatric diagnosis of
childhood, studies on epilepsy among children with ADHD are
few16,21–23 and more knowledge is needed about the occurrence
and clinical characteristics of epilepsy among children with ADHD.
In this paper we study a large sample of children ages 6–14
diagnosed with ADHD, to which degree they also suffer from
epilepsy, in order to achieve better understanding of these
common comorbid neuropsychiatric disorders. We compared
age, sex, disorders of psychological development, cognitive level,
pharmacological treatment for ADHD, initial response to treatment
and ADHD subtype of children in our cohort with and without
epilepsy. In addition, we compared our data with data from a study
on the prevalence, classiﬁcation and severity of epilepsy in
children in western Norway.24
2. Methods
2.1. Design
This is a retrospective chart-review of children with ADHD.
2.2. Material
The medical records of children aged 6–14 years and diagnosed
with ADHD between January 2000 and December 2005 at the
Department of Child and Adolescent Psychiatry, Stavanger
University Hospital, Norway were reviewed. This department is
the only Child and Adolescent Psychiatry department in the area,
and serves a population of 240,000. All patients in the area with
suspected ADHD are referred to the department and it would be
reasonable to assume that ADHD sample is population based.
2.3. Assessment
A structured clinical interview was used to elicit general and
clinical information, including seizures and drug treatment, and a
clinical neurological and child psychiatry examination was
conducted following a structured guide. In addition, standardized
psychiatric instruments including Child Behavior Checklist,25
Conners Parent/Teacher rating scale,26 and ADHD rating scale
IV27 were administered in all children. On the basis of the clinical
interview and the diagnostic procedures, ADHD and subtypes were
diagnosed according to DSM-IV-TR.1 The majority of patients (549;
90.4%) went through the Wechsler Intelligence Scale-Revised
(WISC-R) for intelligence assessment28 and patients with IQ below
50 and those meeting criteria for pervasive developmental
disorder were excluded from the present study. As part of the
routine assessment, digitized 20 min routine EEG with 21
electrodes (10–20 system) was conducted in 517 of the children
with ADHD, including hyperventilation and photic stimulationTable 1
Clinical characteristics of children with ADHD.
Total (N = 607) 
Mean age (SD) at diagnosis of ADHD (years) 9.4 (2.5) 
Gender: male/N (total) (%) 500/607 (82.4%) 
Disorders of psychological development, n/N (%) 367/607, (60.5%) 
IQ < 85 n/N (%) 135/549, (24.6%) 
ADHD-I n/N (%) 73/607, (12.0%) 
a p-Value from statistical comparison of data from group with and without epilepsyduring wakefulness without sleep deprivation. An additional sleep
EEG was performed in 15 cases. Epilepsy was deﬁned as two or
more epileptic seizures occurring at least 24 h apart, and
unprovoked by any immediate identiﬁable cause.29 The epilepsy
was deﬁned as active if at least one seizure had occurred during the
last 5 years, regardless of antiepileptic drug (AED) treatment, and
refractory if the patient continued to experience seizures during
the last year of follow-up, despite a previous adequate trial of more
than two appropriately selected AEDs. Epileptic seizures and
syndromes were classiﬁed according to the international classiﬁ-
cation system of The International League Against Epilepsy,30,31
and identiﬁed by review of the medical records, including the
clinical description of seizures, the results of a neurological
examination, EEG and neuroimaging ﬁndings. All the medical
documentation for each patient that was diagnosed with epilepsy
was reviewed by a child neurologist/child psychiatrist (ﬁrst author,
D.S.) and by a neurologist (second author, D.A.). Epilepsy
syndromes were classiﬁed according to the available information
at the time of ADHD diagnosis. Demographic data and seizure
history including age of onset, duration of epilepsy, medication
status regarding AED treatment and degree of seizure control
during the last year (seizure free, 1–12 seizures per year, and >12
seizures per year) were recorded. AED treatment was classiﬁed as
untreated, monotherapy or polytherapy. In addition we recorded
and analyzed data about disorders of psychological development
(speciﬁc developmental disorders of speech and language,
scholastic skills, motor function, other disorders of psychological
development, and unspeciﬁed disorder of psychological develop-
ment) according to the ICD-10,32 IQ level (IQ > 85, IQ < 85), the
sequence of occurrence of seizures in relationship to the diagnosis
of ADHD, length of time between seizure diagnosis and ADHD
diagnosis, ADHD subtype, pharmacological treatment for ADHD
and initial response to this treatment, deﬁned as positive response
if signiﬁcant reduction in ADHD symptoms scores assessed with
ADHD IV rating scale was shown.27
2.4. Statistical analysis
Demographic and clinical variables in subjects with and
without epileptic seizures were compared using Student’s t-test
for continuous and normally distributed data, and nonparametric
tests for categorical or non-normally distributed data. A p-value of
<0.05 was considered statistically signiﬁcant. The study was
approved by the Norwegian Data Inspectorate and by the Regional
Committee on Medical Research Ethics in region West (nr. 010.07).
3. Results
A total of 607 children (82.4% males) aged 6–14 years with ADHD
were identiﬁed. Of these 14 (2.3%) had a history of epilepsy and 13 of
these had active epilepsy. This is a signiﬁcantly higher occurrence
than previously reported in a Norwegian general pediatric popula-
tion in which 0.5% (198 of 38,593) of children between 6 and 12 years
had epilepsy (p < 0.0001).24 The patients with epilepsy did not differ
from the patients without epilepsy with respect to age, gender,
disorders of psychological development, IQ level < 85 or ADHDWith epilepsy (N = 14) Without epi. (N = 593) p-valuea
8.2 (2.3) 9.4 (2.5) 0.07
10/14, (71.4%) 490/593, (82.6%) 0.5
7/14, (50%) 360/593, (60.7%) 0.6
5/14, (35.7%) 130/544, (23.9%) 0.5
4/14, (28.6%) 69/593 (11.6%) 0.1
.
Table 2
Clinical characteristics of epilepsy among 14 children with ADHD.
Epilepsy syndrome Gender Age at ADHD
diagnosis
(mean: 8.2 y.)
Age at
ﬁrst ESz
(mean: 6.4 y.)
Seizure
types
EEG
interictal
AED at
ADHD dg
ADHD
C or I
Effect of
MPH+/
Localization related
Idiopathic
BECTS M 7 7 P + sGTCSz FEA – C +
BECTS M 7 7 P + sGTCSz FEA CBZ C +
CEO M 8 6 P + sGTCSz FEA VPA C +
Symptomatic
M 7 5 P FEA LTG + TPM C +
Cryptogenic
M 6 6 P + sGTCSz NEA VPA C +
F 5 2 P + sGTCSz NEA LEV C +
F 9 3 P + sGTCSz GEA CBZ C +
M 8 4 P FEA OXC C +
M 8 7 P GEA TPM + ESM I 
F 12 11 P + sGTCSz GEA OXC I +
Generalized
Idiopathic
EGMA M 13 9 GTCSz GEA – C +
CAE F 11 11 Absences GEA VPA C +
CAE M 7 7 Absences GEA LTG I +
Undetermined
Epilepsies with GTCSz and P LKS M 7 5 P FEA SUL I 
ADHD-C, attention deﬁcit/hyperactivity disorder predominantly combined subtype; ADHD-I, attention deﬁcit/hyperactivity disorder predominantly inattentive subtype;
BECTS, benign childhood epilepsy with centrotemporal spikes; CAE, childhood absence epilepsy; CBZ, carbamazepine; CEO, childhood epilepsy with occipital paroxysms;
EGMA, epilepsy with grand mal on awakening; ESM, ethosuximide; ESz, epileptic seizures; FEA, focal epileptiform activity; GEA, generalized epileptiform activity; GTCSz,
generalized tonic clonic seizures; LEV, levetiracetam; LTG, lamotrigine; LKS, Landau-Kleffner syndrome; MPH, methylphenidate; NEA, no epileptiform activity; OXC,
oxcarbazepine; P, partial seizures; sGTCSz, secondary generalized tonic clonic seizures; SUL, sulthiame; TPM, topiramate; VPA, valproate.
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with epilepsy on average 1.8 years before the ADHD assessment. The
clinical characteristics of the children with ADHD and a history of
epilepsy are summarized in Table 2. Eleven (78.6%) of the children
had been seizure-free for at least one year before ADHD assessment.
Two of the children had 1–12 seizures per year, and one had >12
seizures per year. Two of the children, both seizure-free patients,
were not treated with an AED. Ten children were on AED
monotherapy; valproate (VPA) in 3 patients, carbamazepine (CBZ)
in two, oxcarbazepine (OXC) in two, lamotrigine (LTG) in one,
levetiracetam (LEV) in one and sulthiame (SUL) in one. Two patients
were on polytherapy. One child with symptomatic epilepsy
(hypothalamic tumor) was treated with combination of LTG and
topiramate (TPM), and a second case (cryptogenic etiology) with
TPM and ethosuximide (ESM). None of our patients were treated
with phenobarbital (PB) or phenytoin (PHT). Of the 14 patients with
a history of epilepsy, 11 (78.6%) had focal seizures, seven also had
secondary generalized tonic-clonic seizures and three patients had
only primary generalized seizures. Localization-related epilepsies
were more common (10 cases) than generalized epilepsies (3 cases).
Benign childhood epilepsy with centrotemporal spikes (BCECTS)
was found in two cases and childhood absence epilepsy (CAE) in two
cases. The seizure types and etiologies of the epilepsy are described
for each patient in Table 2. Methylphenidate was the pharmacologi-
cal treatment for ADHD in all 14 children with a history of seizures
and initial response to methylphenidate was achieved in 12 (85.7%).
4. Discussion
This study investigated the prevalence and characteristics of
epilepsy in, to the authors’ knowledge, the largest unselected
cohort of children with ADHD, and the ﬁndings add to the extant
clinical understanding of their relationships. The main ﬁnding in
this study was that 14 children (2.3%) of our cases (N = 607) with
ADHD had history of epilepsy and 13 of these had active epilepsy.
This rate of occurrence of active epilepsy was higher than would beexpected from epidemiological studies in pediatric populations
(0.4–1%).2 Two studies from Norway have reported a similar
prevalence of active epilepsy in the general pediatric population;
0.4% in the age group 0–14 years,33 and 0.5% (198 of 38,593)
between 6 and 12 years.24 The study from western Norway24
reported that symptomatic etiology was diagnosed in 46.7%,
idiopathic in 28.8% and cryptogenic in 24.7%, and seizure freedom
was achieved in 30.8% of the children. However, our ﬁndings differ,
with symptomatic etiology in 14.3%, idiopathic in 35.7% and
cryptogenic in 42.9%, and freedom from seizures was achieved in
78.6%. Our results suggest that the majority of patients with
epilepsy and ADHD diagnosed in our child psychiatric department
had mild (an easily treated) epilepsy and were seizure free. This is
in contrast to the results from epidemiological studies in pediatric
population.24,33,34
Seizure types/epileptic syndromes in our study were more
often partial/localization related than generalized similar to the
ﬁndings in the Norwegian prevalence study.24 BCECTS, an epileptic
syndrome commonly occurring in school children, was diagnosed
in two cases in our study. One study from Germany has reported an
association between ADHD, rolandic spikes and BCECTS,35 and
another study has also reported that children with BCECTS
exhibited attention problems and aggressive behavior more
frequently than healthy controls.36 Among our three children
with idiopathic generalized epilepsy, two had the syndrome of
childhood absence epilepsy (CAE) and one case had epilepsy with
grand mal on awakening (EGMA). An association between CAE and
ADHD has been previously reported.20 Landau-Kleffner syndrome
(LKS) is a relatively rare epilepsy syndrome; we identiﬁed one
patient with this syndrome even though we had a small sample.
It is usual for boys to predominate amongst children with
ADHD,1 and this was also found in our study. However, amongst
those with epilepsy, the relative proportion of girls was high (28.6%
versus 17.4% of those without epilepsy). An equal male: female
ratio has been reported in studies on epilepsy patients with
ADHD.7,12,37
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Studies on epilepsy in children diagnosed with ADHD are few,
and two of them had small samples of ADHD patients i.e. 68 and
28.22,23 The largest study that we identiﬁed included 130 patients
with ADHD,21 and reported a higher occurrence of epilepsy (2%)
than expected in the general population (1%). However, only 3
patients had previous histories of epilepsy. All three children had
developmental delays and one was diagnosed with autism one
year after inclusion. The authors suggested that these comorbid
conditions might place them at a much higher risk of epilepsy.
Disorders of psychological development were also common in our
patients (60.5%) (Table 2), but this proportion was not signiﬁ-
cantly higher among those with epilepsy than those without
epilepsy. In addition we analyzed inﬂuence of IQ level. It is
expected that children with IQ < 85 are more likely to have
epilepsy.38 However, our ADHD patients with and without
epilepsy did not differ regarding to IQ < 85 (p = 0.48), thus
supporting an association between epilepsy and ADHD, indepen-
dent of lower IQ level.
A recent study16 compared the incidence and characteristics of
epilepsy among children with (n = 358) and without ADHD
(n = 728). In contrast to other studies whose subjects were already
clinically diagnosed ADHD patients,21–23 in this large study the
diagnosis of ADHD was not made in a clinical setting but were
based on retrospective review of school reports and medical
records until age of 20. Consequently, it may appear uncertain
whether all the included patients actually suffered from ADHD.
Epilepsy was found to occur in 2.2% (8 of 358) of those with ADHD,
compared with 0.8% (6 of 728) in those without ADHD,
representing a 2.7-fold greater incidence of epilepsy among
children with ADHD than in controls. In children with ADHD,
epilepsy appeared to have an earlier onset, was of greater severity
and was less likely to respond to AED treatments. Phenobarbital
(PB) was used in 5 (63%) of their patients and in all cases PB was
stopped prior to the diagnosis of ADHD. Among children with
ADHD symptoms, those with epilepsy were less likely to receive a
clinical diagnosis and treatment of ADHD than those without
epilepsy, possibly reﬂecting a reluctance to diagnose and treat
ADHD symptoms in children with epilepsy. In contrast to these
results, in our study, all patients diagnosed with epilepsy received
medical treatment (methylphenidate) for ADHD, and epilepsy co-
morbidity was apparently not considered as a reason for not
treating ADHD. The majority of our patients had mild (an easily
treated) epilepsy and AED treatment was successful. Of antiepi-
leptic drugs which are particularly recognized to have cognitive
and behavioral side effects that may resemble symptoms of ADHD
(barbiturates, benzodiazepines and LEV),39 among our patients LEV
was monotherapy in one patient, but none of our patients was
treated with PB or a benzodiazepine.
4.2. ADHD subtype and epilepsy
Several studies have reported that the ADHD-I subtype was
more common in children with epilepsy,7,12,18,37,40,41 and in cases
with epileptiform EEG abnormalities42 than in children with ADHD
alone. One population based case control study of newly diagnosed
unprovoked seizures among Icelandic children younger than 16
years, reported that they were 2.5-fold more likely than age- and
sex-matched controls to have a parent-reported history of ADHD-I
before seizure onset.41 Another study involving tertiary care
samples of 175 children with epilepsy without signiﬁcant
developmental delays who had at least a 6 months history of
epilepsy found that children with epilepsy were at higher risk for
symptoms of ADHD than the general population.7 They differed
from the other samples of children with ADHD by having a largerproportion of children with ADHD-I and by equal incidence in
males and females. It might be important to note that 71.4%
children in our sample with epilepsy and ADHD had ADHD-C, a
ﬁgure that differs from studies of ADHD in epilepsy samples that
found more than 50% of children had ADHD-I.7 Different results
may be explained by selection of patients. Our results represent the
child psychiatry population (ADHD patients with epilepsy) which
usually has combined type of ADHD more often than inattentive
type of ADHD.
There are many possible explanations for an association
between ADHD and epilepsy. Patients with epilepsy and ADHD
may have many factors that inﬂuence occurrence of the ADHD-I,
for example, subtle epileptic seizures, transient effects of frequent
epileptiform discharges, antiepileptic treatment and underlying
neurodevelopmental vulnerability. It is interesting to note that all
our patients had already been diagnosed with epilepsy before they
were diagnosed with ADHD. Those with epilepsy tended to have a
younger age at ADHD assessment than those without epilepsy (8.2
vs. 9.4 years). None of the children were being treated with PB or
benzodiazepines which could mimic ADHD symptoms, suggesting
that neurodevelopmental vulnerability and epilepsy diagnosis
with its complexity might contribute to the variation and
determination in ADHD subtype. This ﬁnding supports that after
the diagnosis of epilepsy, ADHD symptoms or ADHD may occur
with a greater frequency than expected. It would be interesting to
ﬁnd out if ADHD patients without previous history of epilepsy
(with and without epileptiform abnormalities) have increased risk
for epileptic seizures occurrence during follow-up and this
question should be investigated in further studies. An increased
risk for epileptic seizures has also been reported among pediatric
patients with psychiatric diagnoses other than ADHD.43 However,
for children with ADHD, particular attention is warranted. ADHD
symptoms may precede, occur simultaneously with, or occur
subsequent to a diagnosis of epilepsy. From a clinical perspective, it
is important to be able to differentiate between the onsets of
epilepsy and ADHD, and to be able to determine whether a patient
with both conditions should receive AED treatment or pharmaco-
logical treatment for ADHD, or both, and on what time scale. In our
study we identiﬁed three patients who were assessed for epilepsy
and for ADHD simultaneously. From the information available at
assessment, it was not obvious whether they actually suffered
from ADHD or whether their symptoms originated from unrecog-
nized ESz (staring, complex partial seizures, absences). After
careful assessment, and following diagnosis of epilepsy, these
children were also diagnosed with ADHD. Our results highlight the
need for carefully assessment of children with ADHD, especially
those with ADHD-I. The differential diagnosis of epilepsy vs. ADHD
might be difﬁcult, but it is important to recognize that they are not
mutually exclusive. Research directed toward identifying the
clinical course of epilepsy and ADHD symptoms in children with
both conditions could provide information of clinical signiﬁcance.
It could allow better assessment and evaluation, and reduce
medical overtreatment of these common neuropsychiatric dis-
orders.
4.3. Limitations and strengths of study
Our study has a retrospective, cross-sectional design, and thus
there is a risk that epilepsy was under-diagnosed. However,
inﬂuence of co-morbid disorders was considered regarding
developmental delays and cognitive level, and patients with
autism spectrum disorder and IQ < 50 were excluded. Strengths
include the relatively large and unselected cohort, as all children
with suspected ADHD were referred to the center and were
clinically diagnosed with ADHD although the number of children
with epilepsy was small.
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on any characteristic, only trends. This could be type II errors due
to small sample size.
5. Conclusions
The epilepsy diagnosis preceded the ADHD diagnosis in all
patients, and was found in 2.3% which is signiﬁcantly higher than
would be expected in the general pediatric population. The majority
of patients had mild epilepsy and ADHD-C. All cases with epilepsy
were treated with MPH, with initial response achieved in 86%.
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